Anti-KCNIP2 antibodies are used in the immunodetection of the protein potassium voltage-gated channel interacting protein 2. In humans, the canonical protein has a reported length of 270 amino acid residues and a mass of 30.9 kDa. Its subcellular localization is in the cell membrane. Up to 9 different isoforms have been reported for this protein. It is reported to be expressed in the brain. A member of the Recoverin protein family, KCNIP2 is a regulatory subunit of Kv4/D (Shal)-type voltage-gated rapidly inactivating A-type potassium channels. Post-translational modifications have been described, including palmitoylation. Synonyms for this target antigen include Kv channel-interacting protein 2, A-type potassium channel modulatory protein 2, Kv channel interacting protein 2, cardiac voltage-gated potassium channel modulatory subunit, and KCHIP2. KCNIP2 gene orthologs have been reported in the mouse, rat, bovine, frog, chimpanzee and chicken species. A number of KCNIP2 antibodies have been mentioned in research publications and have associated citations. Western Blot is a widely used application for these antibodies. In addition, Immunohistochemistry is also a common application.